About MBX Biosciences
Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Carmel, IN
- Founded
- 2019
- Company type
- Public Company
- Company profile name
- MBX Biosciences, Inc.
MBX Biosciences is a clinical-stage biopharmaceutical company based in Carmel, Indiana and Burlington, Massachusetts, on a mission to transform the lives of people living with obesity and rare endocrine disorders.
Leveraging its proprietary peptide delivery platform, MBX is pioneering investigational Precision Endocrine Peptides (PEPs)™ designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience.
The Company is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval and strong market potential.
The Company’s lead candidate, canvuparatide (MBX 2109) – a potential once-weekly parathyroid hormone (PTH) replacement therapy for the treatment of chronic hypoparathyroidism – is preparing for Phase 3 development. The Company’s obesity portfolio includes MBX 4291, a GLP-1/GIP co-agonist prodrug in Phase 1 development, and MBX 5765, an amycretin prodrug in preclinical development. In addition, the Company is on track to nominate its GLP-1/GIP/GCG receptor prodrug candidate in Q3 2026, further expanding its obesity pipeline to potentially address the full spectrum of patient needs.
MBX was founded by pioneers in peptide drug development with a strong track record of building companies at the forefront of endocrine and metabolic disease innovation.
Learn more about our pipeline and scientific foundation on our website.
Company locations
Carmel, IN 46032, US
Burlington, MA 01803, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Wellness
- Biotechnology
- Therapeutics
On LinkedIn
- Followers
- 11,298
- People linked to this company
- 88
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
238,400,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.